The Respiratory Panel Challenge Now Faced by Payers With the Ending of the PHE

Managed Healthcare Executive Features Avalon EVP, Provider Networks Mike Snyder

The end of the Public Health Emergency (PHE) for COVID-19 means more than just returning to business as usual for labs. Health plans are no longer required to reimburse labs for COVID-19 testing at 100% of billed charges, and as labs begin to see a reduction in reimbursements, payers should be keeping a keen eye on a new trend emerging across previously highly reimbursed codes approved by the Centers for Medicare & Medicaid Services. In a Managed Healthcare Executive article, Avalon EVP, Provider Networks, Mike Snyder details how Lab Benefit Managers are uniquely managing laboratory testing at scale.

Read more at Managed Healthcare Executive.

mike_snyder_managed_healthcare_thumbnail
Preview of 2024 Lab Trend Report - Key Insights & Takeaways

Tuesday, May 7
2 – 3 p.m. EST

Connect With Us

Want to get in touch? We’d love to hear from you.